$6.54
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Inogen, Inc. is a global medical technology company offering innovative respiratory products for use in the homecare setting. The company is headquartered in Goleta, California and currently employs 753 full-time employees. The company went IPO on 2014-02-14. The firm partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. The company develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. The company also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Country

US

CEO

Mr. Kevin Smith

IPO date

2014

Employees

753

ISIN

US45780L1044

Key stats

Open

$6.50

Volume

123.39K

Market cap

$176.80M

Prev. close

$6.53

Impl / hst vl

-

Open interest

$0.00

$6.40

Day’s Range

$6.57

$5.34

52W Range

$7.67

Valuation

72
Valuation score
Undervalued
P/E
-
P/S
0.50
P/B
0.96
Current ratio
3.10
Debt / Equity
-0.51
ROE
-12.90%
Gross margin
44.49%
Income growth
16.80%
FCF growth
125.22

Analysts estimates

Consensus rating
Buy

The average rating from top 6 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$12.24
The top 4 analysts forecasts that 12-month price may increase by 87.16%, with a low of $12.12 and a high of $12.60
$12.12
Low
$12.24
Avg
$12.60
High
Current price

Earnings

Q1 ‘26 revenue
$85.11M
Q1 ‘26 net income
-$8.32M
Revenue
Net income
Previous EPS
-$0.30
Estimate EPS
-$0.16
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply